Physician

Ali Rammal, M.D.

According to 2025 Medicare claims, Ali Rammal, M.D. (NPI: 1194741231) practices family practice in the Monroe, MI market, with the plurality of this provider's patient population coming from Monroe, MI. This provider's primary affiliated billing organization is MONROE URGENT CARE INC (NPI: 1205037603; TIN: 260188188) and primary practice location at 48162-4393.

Rammal's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 265 traditional Medicare patients, billed 2,346 HCPCS/CPT codes, and received $35,222 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 886 prescription claims across 421 beneficiaries totaling $12,310 in drug costs, led by Amoxicillin-Clavulanate Potass (Amoxicillin/Potassium Clav). 2021 DME data shows 12 claims. Open Payments data shows 3 records totaling $50. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $156,074 and ending at $35,222. Concurrently, Part D prescription costs have declined steadily, from $57,299 to $12,310. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	825	8,343	$156,074
2016	741	5,042	$102,747
2017	355	2,172	$47,708
2018	294	1,767	$34,284
2019	481	3,215	$63,186
2020	446	3,186	$65,783
2021	1,001	6,257	$207,770
2022	671	4,403	$132,203
2023	507	4,090	$79,289
2024	265	2,346	$35,222

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	722	1,696	$57,299
2016	447	914	$42,194
2017	404	809	$29,003
2018	418	792	$31,850
2019	575	1,243	$46,785
2020	390	928	$46,729
2021	596	1,314	$36,969
2022	682	1,481	$29,545
2023	504	1,080	$22,042
2024	421	886	$12,310

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	12	$69
2021	N/R	12	$65
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	169	235	$77
96372	Injection of drug or substance under skin or into muscle	175	628	$9
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	131	150	$1
J0696	Injection, ceftriaxone sodium, per 250 mg	129	592	$0
J1100	Injection, dexamethasone sodium phosphate, 1 mg	145	190	$0

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	59	588	$553
Methylprednisolone	Methylprednisolone	62	372	$384
Azithromycin	Azithromycin	93	465	$292
Cefdinir	Cefdinir	25	247	$268
Prednisone	Prednisone	146	1,209	$243

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	3	$50	GlaxoSmithKline, LLC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ali Rammal, M.D.?

Tedicare shows public-source Medicare data for Ali Rammal, M.D. (NPI 1194741231), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ali Rammal, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ali Rammal, M.D.?

Ali Rammal, M.D. is linked to MONROE URGENT CARE INC (billing NPI 1205037603) in the available physician profile data.

Does Ali Rammal, M.D. have Open Payments data?

Ali Rammal, M.D. has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.